Anagrelide hydrochloride monohydrate

Remacemide hydrochloride.

An orally bioavailable inhibitor of HDAC1, HDAC3, and HDAC6 (IC₅₀s = 43-72 nM), resulting in hyperacetylation of histone H4 in multiple myeloma cells abrogates cell growth and strongly induces apoptosis in multiple myeloma cells

An orally bioavailable inhibitor of HDAC1, HDAC3, and HDAC6 (IC₅₀s = 43-72 nM), resulting in hyperacetylation of histone H4 in multiple myeloma cells abrogates cell growth and strongly induces apoptosis in multiple myeloma cells

An orally bioavailable inhibitor of HDAC1, HDAC3, and HDAC6 (IC₅₀s = 43-72 nM), resulting in hyperacetylation of histone H4 in multiple myeloma cells abrogates cell growth and strongly induces apoptosis in multiple myeloma cells

An orally bioavailable inhibitor of HDAC1, HDAC3, and HDAC6 (IC₅₀s = 43-72 nM), resulting in hyperacetylation of histone H4 in multiple myeloma cells abrogates cell growth and strongly induces apoptosis in multiple myeloma cells

InformationRibociclib hydrochloride Ribociclib (LEE011) hydrochloride is a highly specific dual inhibitor of CDK4 and CDK6 with IC50 of 10 nM and 39 nM, respectively.TargetsCDK4 (Cell-free assay): CDK6 (Cell-free assay) 10 nM: 39 nM.

Ribociclib-d 6 (hydrochloride) is a deuterium labeled Ribociclib. Ribociclib is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1

RN 9893 hydrochloride.

RN 9893 hydrochloride.

Robenidine Hydrochloride.

Robenidine Hydrochloride.

Robenidine Hydrochloride.